Position in GERN
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$150,200
-$24,620 QoQ
Shares Held
117,344
+0.0% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#112
of 258 holders
Holding Since
Jun 2021
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GERN Over Time
Shares Held
Position Value (USD)
Derivatives in GERN
reported options exposure · as of Sep 30, 2025CallValue
$0
CallShares
0
PutValue
$9,590
PutShares
7,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026HighTower Advisors, LLC holds $312,855,129 across 115 Biotechnology names. GERN ranks #72 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INBX |
Inhibrx Biosciences, Inc.
|
870,551 | $82,484,707 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
64,650 | $40,311,861 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
105,045 | $31,621,696 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
49,020 | $24,349,704 | |
| 5 | RPRX |
Royalty Pharma plc
|
285,630 | $16,015,274 | |
| 6 | EXEL |
Exelixis, Inc.
|
291,162 | $15,842,124 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
56,313 | $13,783,733 | |
| 8 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
140,394 | $11,443,514 |
All Filings in GERN
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $150,200 | 117,344 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $174,820 | 117,329 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $154,709 | 117,204 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $163,330 | 119,219 | Shares | Sole | 2025-11-07 | |
| 2025-09-30 | $9,590 | 7,000 | Put | Sole | 2025-11-07 | |
| 2025-06-30 | $84,246 | 59,749 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $14,310 | 9,000 | Call | Sole | 2025-05-13 | |
| 2025-03-31 | $58,430 | 36,749 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $127,585 | 36,041 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $122,915 | 27,074 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $124,732 | 29,418 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $102,788 | 31,148 | Shares | Sole | 2024-05-06 | |
| 2024-03-31 | $6,600 | 2,000 | Call | Sole | 2024-05-06 | |
| 2023-03-31 | $30,455 | 14,035 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $33,964 | 14,035 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $32,841 | 14,035 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $19,993 | 12,899 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $17,542 | 12,899 | Shares | Sole | 2022-05-12 | |
| 2021-06-30 | $18,753 | 13,300 | Shares | Sole | 2021-08-06 | |
| No filing history on record for this holder in this stock. | ||||||